Laxminarayan Bhat
2021
In 2021, Laxminarayan Bhat earned a total compensation of $600.1K as Chief Executive Officer and President at REVIVA PHARMACEUTICALS HOLDINGS, a 142% increase compared to previous year.
Compensation breakdown
Bonus | $200,054 |
---|---|
Salary | $400,000 |
Total | $600,054 |
Bhat received $400K in salary, accounting for 67% of the total pay in 2021.
Bhat also received $200.1K in bonus.
Rankings
In 2021, Laxminarayan Bhat's compensation ranked 10,317th out of 12,406 executives tracked by ExecPay. In other words, Bhat earned more than 16.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,317 | 17th |
Manufacturing | 4,566 | 17th |
Chemicals And Allied Products | 2,043 | 14th |
Drugs | 1,812 | 13th |
Pharmaceutical Preparations | 1,342 | 13th |
Bhat's colleagues
We found two more compensation records of executives who worked with Laxminarayan Bhat at REVIVA PHARMACEUTICALS HOLDINGS in 2021.